Predict your next investment

Corporation
myrx365.com

See what CB Insights has to offer

About MYRX365

MYRX365 uses technology to fulfill patient prescriptions.

MYRX365 Headquarter Location

New York, New York,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MYRX365

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find MYRX365 in 1 Expert Collection, including Telehealth.

T

Telehealth

2,810 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Latest MYRX365 News

MYRX365 Announces Physician Advisory Board & Joins StartUp Health

Nov 26, 2019

On August 17, 2019, tech-enabled pharmacy company, MYRX365, Inc. announced the addition of 12 physicians to its medical advisory board. Each of these physicians brings practice area expertise relating to the treatment of chronic disease and post- surgical care. The advisory board will work with the company to advise on relevant drug therapies and opioid alternatives to pain management. The advisory board includes the following physicians: Ram Raju, MD Surgery Armand Dorian, MD Emergency Medicine Chief Medical Officer at University of South California - VHH Leonard Achan, RN, MA Hospital Innovation Chief Innovation Officer at Hospital for Special Surgery Umesh Gidwani, MD Cardiology Harvey Himel, MD Plastic Surgery Medical Director of Wound Center at Mt. Sinai Hospital Jose Tiburcio, MD Primary Care Associate Chair of Family Medicine at Bronx Lebanon Hospital Syed Nasir, MD Anesthesiology Deepjot Singh, MD OB/GYN Ali Khan, MD Internal Medicine Associate Medical Director of Hospital Medicine at SUNY Upstate Medical University Donald Cross, MD Cardiology CHRISTUS Health General Surgeon – Memorial Hermann Hospital System Sharad Swami, MD Internal Medicine Partner - Prime Choice Urgent Care MYRX365 CEO, Mohammad Ali, MD states “We are thrilled to add this group of talented medical leaders to our team as the company seeks to perfect the care triangle created by patients, physicians and pharmacy.” MYRX365 is also now part of the StartUp Health portfolio. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers® -- committed to achieving Health Moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, End Addiction, Women’s Health, Children’s Health, Nutrition & Fitness, Brain Health, Mental Health & Happiness, Longevity, and Addiction. Backed by Advocate Aurora Health, Chiesi Group, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente Ventures, Masimo, Novartis, Otsuka, Ping An Group, and SeventySix Capital, StartUp Health has the world’s largest digital health portfolio with more than 290 companies spanning six continents and 24 countries. Learn more at startuphealth.com . About MYRX365 MYRX365, a StartUp Health portfolio company, is a tech-enabled pharmacy leveraging consumer-oriented data and the latest in fulfillment technologies to improve adherence and patient engagement in the prescription drug therapy marketplace. The company’s unique suite of technology tools effectively creates a real-time care triangle, linking patients, providers and pharmacy to maximize engagement and adherence. For the original version on PRWeb visit: https://www.prweb.com/releases/myrx365_announces_physician_advisory_board_joins_startup_health/prweb16742443.htm

MYRX365 Acquisitions

1 Acquisition

MYRX365 acquired 1 company. Their latest acquisition was RealTime Clinic on April 10, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/10/2019

$99M

Acquired

1

Date

4/10/2019

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.